For citations:
Klefortova I.I. European Medicines Agency (EMA) announces termination of Avandia (rosiglitazone usage in Europe). Diabetes mellitus. 2010;13(3):158-159. (In Russ.) https://doi.org/10.14341/2072-0351-5509
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
